When clinical studies demonstrated that GLP1 drugs (e.g., semaglutide, tirzepatide), developed to treat diabetes, are effective weight loss drugs that directly act on the brains satiety center to reduce food intake (also drink less alcohol and smoke fewer cigarettes) doctors began prescribing them to help reduce the health risks associated with obesity
Consulting with a healthcare professional, such as the experts at DHH Med Spa, and following their guidance is crucial to ensure a safe and effective weight loss journey
Clinical trials have extended beyond two years, and the safety profile appears acceptable for ongoing use
Experimental studies in this area often evaluate food intake, satiety-related responses, feeding patterns, and associated endocrine biomarkers
With 20g of protein and only 330 calories , it also boasts the best protein-to-calorie ratio on the menu[2]
doi:10.1016/j.diabres.2014.01.010